NPI: 1386016541 · ALBUQUERQUE, NM 87109 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/28/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/28/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,861 | $164K |
| 2019 | 1,913 | $40K |
| 2020 | 2,441 | $19K |
| 2021 | 3,357 | $146K |
| 2022 | 4,905 | $80K |
| 2023 | 6,149 | $594K |
| 2024 | 4,034 | $152K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,832 | 1,332 | $1.15M |
| J1756 | Injection, iron sucrose, 1 mg | 661 | 166 | $26K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 2,276 | 170 | $10K |
| A4657 | Syringe, with or without needle, each | 783 | 519 | $8K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 45 | 29 | $903.00 |
| 82728 | 325 | 276 | $69.34 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 294 | 146 | $41.74 |
| 83550 | 213 | 177 | $32.61 | |
| 85041 | 801 | 709 | $29.47 | |
| 83970 | 292 | 265 | $25.16 | |
| 85048 | 802 | 709 | $24.92 | |
| 83540 | 310 | 265 | $24.19 | |
| 82108 | 26 | 25 | $0.00 |